In this interactive episode, Dr. Joshua Dunaief answers listener questions about macular degeneration. From understanding the different types of AMD to the role of supplements and nutrition, tips for daily living, and treatment options, this conversation is designed to address the topics that matter most to you. Join us to hear practical insights from a leading expert.

Staying on schedule with wet age-related macular degeneration (AMD) treatment is one of the most important ways to protect your vision. In this episode, Manuel Amador, MD, explains today’s wet AMD treatments and why consistency matters. He will also share practical tips on early detection, risk factors, and taking an active role in your eye health.

What if an artificial retina or another type of electronic implant could restore vision? Unlike current therapies that only slow the progression of the disease, retinal prostheses are designed to actually restore vision for people with retinal degeneration. In this Macular Chats episode, we explore this emerging field and break down the different types of implants in development, including the PRIMA implant—the only retinal prosthesis currently in production and the first viable treatment for geographic atrophy from AMD—and look ahead to what’s next in the research pipeline.

In recognition of National Caregivers Month, this episode explores the vital role of those who support individuals living with vision loss—whether family members, professionals, or volunteers. Our guests will discuss the emotional, physical, and financial challenges care partners face and share practical resources to help support them.

Stem cell research is offering new possibilities for treating age-related macular degeneration (AMD), a leading cause of vision loss. In this Macular Chat, Dr. Jeffrey Stern and Dr. Sally Temple, Principal Investigators and Co-Founders of the Neural Stem Cell Institute, will explain what stem cells are, share the latest updates from clinical trials such as Luxa Biotechnology’s RPESC-RPE transplantation, and discuss the safety, outcomes, and future potential of stem cell therapies. They will also address what these advances mean for patients and caregivers today, what clinical trials are available, and what timelines might look like for making these treatments more widely accessible.